Teva Pharmaceutical Industries and AbbVie’s Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said on Wednesday.
https://www.pharmalive.com/wp-content/uploads/2020/08/U.S.-sues-Teva-over-alleged-kickbacks-for-multiple-sclerosis-drug-Reuters-8-18-20.jpeg246370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-05-25 13:26:392022-05-25 20:19:05Teva, Allergan reach $161.5 million opioid settlement with West Virginia
